Literature DB >> 17632413

Interferon gamma: friend or foe?

Kathryn J Wood1, Gang Feng, Bin Wei, Birgit Sawitzki, Andrew R Bushell.   

Abstract

Interferon gamma (IFN-gamma) can elicit an inflammatory TH1-driven immune response but has also been found to be necessary for long-term allograft survival induced by costimulation blockade. Recently, we have found that regulatory T cells rapidly and transiently produce IFN-gamma creating a microenvironment that can influence the function of antigen presenting cells (APCs), T-cell proliferation and activation as well as T-cell effector mechanisms, thereby controlling immune responses locally. Moreover, addition of IFN-gamma to cocultures of T cells and APCs can drive the generation of T cells with regulatory activity. Thus, the influence of IFN-gamma on the immune response to a transplant is likely to be context dependent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632413     DOI: 10.1097/01.tp.0000269115.60728.b1

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

Review 1.  Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions.

Authors:  Stephen C Juvet; Li Zhang
Journal:  J Mol Cell Biol       Date:  2012-02       Impact factor: 6.216

Review 2.  Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Cytokine       Date:  2017-04-25       Impact factor: 3.861

3.  IFNγ inhibits G-CSF induced neutrophil expansion and invasion of the CNS to prevent viral encephalitis.

Authors:  Chandran Ramakrishna; Edouard M Cantin
Journal:  PLoS Pathog       Date:  2018-01-19       Impact factor: 6.823

4.  Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity?

Authors:  Bruce M Hall; Giang T Tran; Nirupama D Verma; Karren M Plain; Catherine M Robinson; Masaru Nomura; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2013-08-02       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.